Harvard Bioscience
HBIO
#10521
Rank
NZ$65.71 M
Marketcap
NZ$14.44
Share price
-1.32%
Change (1 day)
1,975.13%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -NZ$18.34 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are NZ$87.8 Million. In 2025 the company made an earning of -NZ$0.11 Billion a decrease over its 2024 earnings that were of -NZ$20.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$18.34 Million-81.78%
2025 -NZ$0.11 Billion391.95%
2024 -NZ$20.47 Million356.38%
2023 -NZ$4.49 Million-72.15%
2022 -NZ$16.1 Million6456.43%
2021 -NZ$0.25 Million-98.08%
2020 -NZ$12.8 Million32.53%
2019 -NZ$9.66 Million-31.01%
2018 -NZ$13.99 Million243.9%
2017 -NZ$4.07 Million-24.66%
2016 -NZ$5.4 Million-14.69%
2015 -NZ$6.33 Million-181.68%
2014 NZ$7.74 M-9.97%
2013 NZ$8.6 M120%
2012 NZ$3.91 M-50.9%
2011 NZ$7.96 M-52.51%
2010 NZ$16.77 M-2.53%
2009 NZ$17.21 M28.26%
2008 NZ$13.41 M-20.05%
2007 NZ$16.78 M13.96%
2006 NZ$14.72 M17.59%
2005 NZ$12.52 M57.37%
2004 NZ$7.95 M-37.31%
2003 NZ$12.69 M208.03%
2002 NZ$4.12 M-168.71%
2001 -NZ$6 Million-66.89%
2000 -NZ$18.12 Million